The partial agonist of the dopamine receptor 2, Aripiprazole, facilitates extinction in adolescent rats

被引：0
|
作者：
Ganella, D. E. [1 ]
Madsen, H. B. [1 ]
Zbukvic, I. C. [1 ]
Coulthard, R. W. [1 ]
Lee-Kardashyan, L. [1 ]
Lawrence, A. J. [1 ]
Kim, J. H. [1 ]
机构：
[1] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia
来源：
JOURNAL OF NEUROCHEMISTRY | 2014年 / 130卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
YIC06-2
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [1] Aripiprazole Facilitates Extinction of Conditioned Fear in Adolescent Rats
    Ganella, Despina E.
    Lee-Kardashyan, Liubov
    Luikinga, Sophia J.
    Nguyen, Danny L. D.
    Madsen, Heather B.
    Zbukvic, Isabel C.
    Coulthard, Russell
    Lawrence, Andrew J.
    Kim, Jee Hyun
    [J]. FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2017, 11
  • [2] Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic
    Keck, PE
    McElroy, SL
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (04) : 655 - 662
  • [3] The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa
    Frank, Guido K. W.
    Shott, Megan E.
    Hagman, Jennifer O.
    Schiel, Marissa A.
    DeGuzman, Marisa C.
    Rossi, Brogan
    [J]. INTERNATIONAL JOURNAL OF EATING DISORDERS, 2017, 50 (04) : 447 - 450
  • [4] Aripiprazole acts as a selective dopamine D2 receptor partial agonist
    Wood, Martyn
    Reavill, Charlie
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (06) : 771 - 775
  • [5] Pharmacology of aripiprazole, a novel antipsychotic:: dopamine D2 receptor partial agonist
    Kikuchi, T
    Arlene, S
    Yocca, F
    Tadori, Y
    Hirose, T
    McQuade, R
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (03) : 190 - 190
  • [6] Aripiprazole, a Partial Dopamine Agonist to Improve Adolescent Anorexia Nervosa-A Case Series
    Frank, Guido K. W.
    [J]. INTERNATIONAL JOURNAL OF EATING DISORDERS, 2016, 49 (05) : 529 - 533
  • [7] Aripiprazole, a dopamine D2 receptor partial agonist activates nuclear CaMKII in dopaminergic neurons
    Sawai, Masahiro
    Shioda, Norifumi
    Fukunaga, Kohji
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 143P - 143P
  • [8] Aripiprazole:: Pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia
    Gründer, G
    Kungel, M
    Ebrecht, M
    Göröcs, T
    Modell, S
    [J]. PHARMACOPSYCHIATRY, 2006, 39 : S21 - S25
  • [9] Aripiprazole as a dopamine partial agonist - Positive and negative effects
    Glick, ID
    Duggal, V
    Hodulik, C
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (01) : 101 - 103
  • [10] The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndrome
    McLean, AJ
    [J]. SLEEP, 2004, 27 (05) : 1022 - 1022
12345